BVF Inc’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,038,528
Closed -$13.4M 64
2020
Q2
$13.4M Buy
2,038,528
+1,055,477
+107% +$3.81M 0.82% 35
2020
Q1
$1.84M Sell
983,051
-103,200
-10% -$272K 0.17% 51
2019
Q4
$2.04M Hold
1,086,251
0.15% 51
2019
Q3
$1.54M Buy
1,086,251
+65,017
+6% +$142K 0.16% 52
2019
Q2
$2.88M Buy
1,021,234
+569,384
+126% +$2.27M 0.31% 48
2019
Q1
$2.15M Hold
451,850
0.24% 49
2018
Q4
$1.92M Buy
451,850
+91,632
+25% +$708K 0.25% 47
2018
Q3
$3.94M Buy
360,218
+25,885
+8% +$303K 0.35% 49
2018
Q2
$5.45M Buy
+334,333
New +$4.84M 0.53% 40

Other funds holding SURF

BVF Inc's SURF Position: Q3 2020 in Review

BVF Inc sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2020, closing a stake of 2,038,528 shares — an estimated $13.4M sold.

BVF Inc first reported a position in SURF in Q2 2018 and held it in 9 quarters. The position peaked at $13.4M in Q2 2020. 59 funds tracked by Wall St. Rank hold SURF as of Q3 2020.

  • BVF Inc reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • BVF Inc sold 2,038,528 Surface Oncology, Inc. Common Stock shares in Q3 2020, an estimated $13.4M.
  • BVF Inc first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • BVF Inc's Surface Oncology, Inc. Common Stock position peaked at $13.4M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2020.

Based on BVF Inc's 13F filing for Q3 2020, filed 13 Nov 2020.